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  This is the ﬁ  rst in a series of two articles that look 
at the lessons for clinical medicine from systems 
biology.
    S
ince Descartes and the 
Renaissance, science, including 
medicine, has taken a distinct 
path in its analytical evaluation of the 
natural world [1,2]. This approach 
can be described as one of “divide 
and conquer,” and it is rooted in the 
assumption that complex problems 
are solvable by dividing them into 
smaller, simpler, and thus more 
tractable units. Because the processes 
are “reduced” into more basic units, 
this approach has been termed 
“reductionism” and has been the 
predominant paradigm of science over 
the past two centuries. Reductionism 
pervades the medical sciences and 
affects the way we diagnose, treat, and 
prevent diseases. While it has been 
responsible for tremendous successes 
in modern medicine, there are limits 
to reductionism, and an alternative 
explanation must be sought to 
complement it.
    The alternative explanation that 
has received much recent attention, 
due to systems biology, is the systems 
perspective (Table 1). Rather than 
dividing a complex problem into 
its component parts, the systems 
perspective appreciates the holistic and 
composite characteristics of a problem 
and evaluates the problem with the use 
of computational and mathematical 
tools. The systems perspective is rooted 
in the assumption that the forest 
cannot be explained by studying the 
trees individually. 
    In order for a systems perspective to 
be fully appreciated, however, we must 
ﬁ  rst recognize the reductionist nature 
of medical science and understand its 
limitations. For this reason, the ﬁ  rst 
article in this series is dedicated to 
examining the reductionist approach 
that pervades medicine and to 
explaining how a systems approach 
(as advocated by systems biology) may 
complement it. In the second article, 
we aim to provide a more practical 
discussion of how a systems approach 
would affect clinical medicine. We hope 
that these discussions can stimulate 
further inquiry into the clinical 
implications of systems principles.
  Current  Medical  Science
    While the   implementation   of clinical 
medicine is systems-oriented, the 
science of clinical medicine is 
fundamentally reductionist. This is 
shown in four prominent practices 
in medicine: (1) the focus on a 
singular, dominant factor, (2) 
emphasis on homeostasis, (3) inexact 
risk modiﬁ  cation, and (4) additive 
treatments.
      Focus on a singular factor.   When the 
human body is viewed as a collection 
of components, the natural inclination 
of medicine is to isolate the single 
factor that is most responsible for 
the observed behavior. Much like a 
mechanic who repairs a broken car by 
locating the defective part, physicians 
typically treat disease by identifying 
that isolatable abnormality. Implicit 
within this practice is the deeply rooted 
belief that each disease has a potential 
singular target for medical treatment. 
For infection, the target is the 
pathogen; for cancer, it is the tumor; 
and for gastrointestinal bleeding, it is 
the bleeding vessel or ulcer. 
    While the success of this approach 
is undeniable, it leaves little room 
for contextual information. A young 
immuno-compromised man with 
pneumococcal pneumonia usually gets 
the same antibiotic treatment as an 
elderly woman with the same infection. 
The disease, and not the person 
affected by it, becomes the central 
focus. Our contemporary analytical 
tools are simply not designed to address 
more complex questions, and, thus, 
questions such as “how do a person’s 
sleeping habits, diet, living condition, 
comorbidities, and stress collectively 
contribute to his/her heart disease?” 
remain largely unanswered.
      Emphasis on homeostasis.   For 
decades, homeostasis has been a 
vital, guiding principle for medicine. 
Claude Bernard in 1865 and later 
Walter B. Cannon popularized this 
principle, expounding on the body’s 
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remarkable ability to maintain stability 
and constancy in the face of stress 
[3]. Since then, homeostasis has been 
incorporated into clinical practice. 
Illness is deﬁ  ned as a failed homeostatic 
mechanism, and treatment requires 
physicians to substitute for this failed 
mechanism by correcting deviations 
and placing parameters within normal 
range. This corrective treatment 
approach is true for a range of medical 
conditions, from hypothyroidism to 
hypokalemia to diabetes. 
    This interpretation of homeostasis, 
however, is biased by a reductionist 
viewpoint in two ways. First, the 
emphasis on correcting the deviated 
parameter (e.g., low potassium) 
belies the importance of systems-
wide operations. Either alternate, 
less intuitive targets may be more 
effective, or correction of the deviated 
parameter may itself have harmful 
system-wide effects. Existing evidence 
that demonstrates adverse effects of 
calcium for hypocalcemia [4,5] or 
blood pressure control for stroke-
related hypertension [6] points to 
the limitations of this homeostasis 
interpretation as a universal principle.
    Secondly, the exclusive focus on 
normal ranges belies the importance of 
dynamic stability. Because reductionism 
often disregards the dynamic 
interactions between parts, the system 
is often depicted as a collection of static 
components. Consequently, emphasis is 
placed on static stability/normal ranges 
and not on dynamic stable states, such as 
oscillatory or chaotic (seemingly random 
but deterministic) behavior. Circadian 
rhythms [7] are an example of 
oscillatory behavior, and complex heart 
rate variability [8–10] is an example 
of chaotic behavior. Failure to include 
these dynamic states in the homeostasis 
model may lead to treatments that are 
either ineffective or even detrimental. 
      Inexact risk modiﬁ  cation.   Since 
disease cannot always be predicted with 
certainty, health professionals must 
identify and modify risk factors. The 
common, unidimensional, “one-risk-
factor to one-disease” approach used 
in medical epidemiology, however, has 
certain limitations.
    An example is hypertension, a known 
risk factor for coronary heart disease. 
Guidelines suggest pharmacological 
and lifestyle treatment for individuals 
with systolic blood pressure greater 
than 140. This strategy is supported by 
evidence from the Framingham Study, 
which showed that men between 35 
and 64 years of age with systolic blood 
pressures greater than 140 were twice 
as likely to develop heart disease as 
compared to individuals with systolic 
blood pressure less than 140 [11]. 
However, given that nearly 70% of the 
American population is not affected by 
hypertension, up to 30% of coronary 
artery disease develops in individuals 
with normal blood pressure [11]. 
Conceivably, a large number of people 
at small risk may give rise to more 
cases of disease than a small number of 
people at high risk. This observation is 
termed the prevention paradox [12].
    To capture these missed cardiac 
events, the natural recourse is to 
progressively lower the blood pressure 
threshold for treatment. Consequently, 
the Joint National Committee on 
Prevention, Detection, Evaluation, and 
Treatment of High Blood Pressure 
lowered its initial diastolic blood 
pressure threshold of 105 in 1977 to 
90 in 1980, to 85 (for high normal) in 
1992, and to 80 (for prehypertension) 
in 2003. The cost of such a strategy 
is the unnecessary treatment of 
individuals who wouldn’t have 
developed coronary disease in the ﬁ  rst 
place. This problem originates from 
the constraints imposed by a one-risk 
to one-disease analysis and the inability 
to work with multiple risk factors and 
calculate their collective inﬂ  uences. 
If a more multidimensional analytical 
method were used, then more precise 
risk projections for individuals could be 
devised. 
      Additive treatments.   In reductionism, 
multiple problems in a system are 
typically tackled piecemeal. Each 
problem is partitioned and addressed 
individually. In coronary artery disease, 
for example, each known risk factor is 
addressed individually, whether it be 
hyperlipidemia or hypertension. The 
strategy is also extended to coexisting 
diseases, such as hypothyroidism, 
diabetes, and coronary artery disease. 
Each disease is treated individually, 
as if the treatment of one disorder 
(such as coronary artery disease) has 
minimal effects on the treatment of 
another (such as hypothyroidism). 
While this approach is easily executable 
in clinical practice, it neglects the 
complex interplay between disease and 
treatment. The assumption is that the 
results of treatments are additive rather 
than nonlinear.
    Limitations to Current Medical 
Science
    The science underlying our 
medical practices, from diagnosis 
to treatment to prevention, is based 
on the assumption that information 
about individual parts is sufﬁ  cient 
to explain the whole. But there are 
circumstances in which the complex 
interplay between parts yields a 
behavior that cannot be predicted 
by the investigation of the parts 
  Table 1.   Reductionism versus a Systems-Oriented Perspective   
Characteristic Reductionism Systems-Oriented Approach
Principle Behavior of a biological system can be explained by the properties 
of its constituent parts
Biological systems possess emergent properties that are only 
possessed by the system as a whole and not by any isolated part 
of the system
Metaphor Machine, magic bullet Network
Approach One factor is singled out for attention and is given explanatory 
weight on its own
Many factors are simultaneously evaluated to assess the dynamics 
of the system
Critical factors Predictors/associated factors Time, space, context
Model characteristics  Linear, predictable, frequently deterministic Non-linear, sensitive to initial conditions, stochastic (probabilistic), 
chaotic 
Medical concepts Health is normalcy  Health is robustness
Health is risk reduction Health is adaptation/plasticity
Health is homeostasis Health is homeodynamics
 DOI:  10.1371/journal.pmed.0030208.t001 
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alone. The failure to account for 
these circumstances is the common 
denominator for the explanations of 
why the aforementioned practices are, 
in many cases, inadequate. 
    So how should these complexities be 
addressed? Is there a formal method that 
can explain how the pieces create the 
whole? How do we shift our lens from 
the parts to the system? The answers 
to these questions may come from a 
relatively new branch of science called 
systems biology [13–16]. Systems biology 
was conceived to address the molecular 
complexities seen in biological systems. 
One major impetus for its creation was 
the human genome project. 
  Human  Genome  Project
    The completion of the human genome 
project in 2003, in addition to the 
development of high-throughput 
technologies such as DNA array 
chips, has led scientists to confront 
a challenge they could not address 
before; namely, how do genes interact 
to collectively create a system-wide 
behavior?
    The human genome contains 30,000 
to 35,000 genes [17]. Although this 
number is just ﬁ  ve times the number 
of genes in a unicellular eukaryote 
(e.g., approximately 6,000 genes 
in   Saccharomyces cerevisiae  ) [18], the 
human genome encodes for nearly 100 
trillion cells in the human body [19]. 
The richness of information is derived 
not only in the genes themselves but 
also in the interaction between genes 
and between their respective products. 
The genes encode for messenger 
RNA, the messenger RNAs encode 
for proteins, and the proteins act as 
catalysts or secondary messengers, 
among other diverse functions. 
Between each hierarchical level, 
modiﬁ  cations (e.g., alternative splicing) 
are made, and at each hierarchical 
level (e.g., transcription), thousands of 
molecules interact with other molecules 
to create a complex regulatory network. 
What becomes evident from these 
molecular analyses is that phenotypic 
traits emerge from the collective action 
of multiple individual molecules [20]. 
Therefore, the previous notion that a 
single genetic mutation is responsible 
for most phenotypic defects is overly 
simplistic. Complex diseases such as 
cancer, asthma, or atherosclerosis 
cannot generally be explained by a 
single genetic mutation.
    Systems Biology: An Introduction
    The need to make sense of complex 
genetic interactions has led some 
researchers to shift from a component-
level to system-level perspective. This 
novel approach incorporates the 
technical knowledge obtained from 
systems engineering, which began 
with Norbert Weiner’s “cybernetics” 
in 1948 and Ludwig von Bertalanffy’s 
“General Systems Theory” in 1969 
[21,22]. The developing ﬁ  elds of 
chaos theory, nonlinear dynamics, and 
complex systems science, along with 
computational science, mathematics, 
and physics, have also contributed to 
the analytical armamentarium used by 
systems analysts.
    The intention of applying these 
theories to biological systems (termed 
“systems biology”) is to understand how 
properties emerge from the nonlinear 
interaction of multiple components 
(Table 2). How does consciousness 
arise from the interactions between 
neurons? How do normal cellular 
functions such as cellular division, 
cell activation, differentiation, and 
apoptosis emerge from the interaction 
of genes? These questions highlight the 
difﬁ  culty of understanding complex 
biological systems—the moment the 
lens is directed toward the components 
of a biological system, the behaviors 
and properties of the whole system 
become obscure. Plainly said, one loses 
sight of the forest for the trees.
    Systems biology is an integrative 
approach that combines theoretical 
modeling and direct experimentation. 
Theoretical models provide insights 
into experimental observations, and 
experiments can provide data needed 
for model creation or can conﬁ  rm 
or refute model ﬁ  ndings. With this 
integrative approach, it becomes 
   E. coli  chemotaxis is an example of 
systems biology’s application (see Figure 
1). Chemotaxis is deﬁ  ned as directed 
motion of a cell toward increasing (or 
decreasing) concentrations of a particular 
chemical substance.   E. coli  has been 
observed to migrate toward areas of 
higher aspartate concentrations through 
a series of “runs” and “tumbles.” The 
“runs” are linear paths taken by the 
bacteria, while the “tumbles” are random 
rotations that reorient the bacteria. When 
bacteria reach higher concentrations 
of aspartate, time spent “running” in 
proportion to “tumbling” increases—the 
logic being that if higher concentrations 
of aspartate are encountered, the 
bacterium is on the right track and 
should continue in that direction. If the 
  E. coli  fails to detect increasing aspartate 
concentrations, the bacterium eventually 
exhibits “adaptation,” where it returns to 
the baseline “tumble and run” activities. 
This ensures that it does not continually 
head in the wrong direction.
    Conventional medical methods have, 
for more than a decade, been able to 
identify the enzymes and molecules 
involved in the chemotactic pathway. 
Despite this, little was known about how 
the interactions in this pathway translated 
to its known chemotactic behavior, 
namely the ability of   E. coli  to “adapt” in a 
large range of aspartate concentrations. 
Spiro, et al. [31] used systems methods 
in 1997 to provide a mechanistic 
explanation. They placed the involved 
enzymes into a mathematical equation 
(context), considered the relationship 
between these enzymes (space), 
and analyzed the activities for each 
enzyme with the use of computational 
tools (time). Increased temporal 
detections of aspartate led to reduced 
autophosphorylation rate of the aspartate 
receptor. This effect reduced the 
tumbling rate and increased the running 
time. When there was no increased 
detection of aspartate, methylation of 
the aspartate receptor occurred, which 
increased the autophosphorylation 
rate and caused the   E. coli  to return to 
prestimulus tumble-and-run activities 
(adaptation). Importantly, this adaptive 
behavior occurred at different aspartate 
concentrations, explaining how   E. 
coli  does not perpetually exist in an 
excited state, even at higher aspartate 
concentrations.
    Similar conceptual breakthroughs have 
been obtained with the use of systems 
methods in other biological phenomena, 
such as bacteriophage lysis-lysogeny 
[32], biological oscillations [33,34], 
circadian rhythms [35,36], and   Drosophila  
development [37–39]. In these situations, 
the incorporation of context, time, and 
space into the equation has provided 
information not otherwise obtained 
through structural information alone. 
  Box 1. Chemotaxis as an Example of Systems Biology’s Application 
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apparent that no single discipline 
is ideal to address systems biology. 
Scientists from molecular biology, 
computational science, engineering, 
physics, statistics, chemistry, and 
mathematics need to cooperate in 
order to explain how the biological 
whole materializes [23].
    While the ﬁ  eld of systems biology 
is young, it has been received 
with substantial enthusiasm. Many 
believe that, without a system-level 
understanding, the beneﬁ  ts of the 
genomic information cannot be fully 
realized. The perceived importance of 
this understanding is reﬂ  ected in the 
investments made by major academic 
and industrial centers within the past 
few years [24].
    Importance of Context, Space, 
and Time
    How is systems-level understanding 
achieved? The answer likely lies in 
the dynamic and changing nature of 
biological networks. Unlike the static 
depiction of many wiring network 
representations, both the molecular 
concentrations and enzyme activities 
are continually changing as a result 
of inﬂ  uences from other molecular 
substrates. The network is an 
interactive and dynamic web in which 
the properties of a single molecule are 
contingent on its relationship to other 
molecules and the activities of those 
other molecules within the network. 
Therefore, the behavior of the system 
arises from the active interactions 
of these biological components. To 
elicit the system-wide behavior, three 
factors need to be considered: (1) 
context, which values the inclusion of 
all components partaking in a process; 
(2) time, which considers the changing 
characteristics of each component; 
and (3) space, which accounts for the 
topographic relationships between and 
among components. Box 1 and Figure 
1 show an example of how systems 
methods—incorporating context, time, 
and space—allowed researchers to 
provide a mechanistic explanation for 
  Escherichia coli   chemotaxis.
    The three factors of context, time, 
and space play a vital role in systems 
science. Systems biologists consequently 
use tools such as differential equations, 
diffusion functions, computational 
models, and high throughput tools 
to incorporate one or more of these 
factors to address a research question. 
This approach differs from traditional 
medical methods, where the central 
focus is elaborating the instantaneous 
property of a component involved in 
a disease process. In many medical 
models, the process of data extraction, 
such as obtaining serum glucose level 
or blood pressure, can lead to loss of 
information on time, space, or context. 
Systems biologists contend that loss 
of this information leads to loss of 
rich information that would otherwise 
contribute to a better understanding of 
the systemic and dynamic behavior of 
the human body. 
  Systems  Biology  Concepts
    Several concepts have emerged in 
systems biology to describe properties 
occurring at the systems level. One 
prominent concept is robustness, 
deﬁ  ned as the ability to maintain 
  Table 2.   Overview of Systems Biology   
Aspect Description
Deﬁ  nition Systems biology represents the study of biological systems through the 
lens of the “whole.” It incorporates the dynamic relationships between the 
“parts.”
Predecessor General systems theory, cybernetics, information theory, molecular biology, 
and genetics.
Catalyst Human genome project, molecular high-throughput tools, advances in 
computer science.
Scientiﬁ  c disciplines Biology, medicine, physics, mathematics, computer science, engineering, 
chemistry, statistics.
Sample experiments  E. coli  chemotaxis [31, 40, 41], bacteriophage lysis-lysogeny [32], biological 
oscillation [33,42],   Drosophila  development [37–39]
Sample institutes Institute for Systems Biology (Seattle, Washington, United States of America)
Computation and Systems Biology Initiative (MIT, Cambridge, 
Massachusetts, United States of America) 
The Systems Biology Institute (Tokyo, Japan)
Department of Systems Biology (Harvard Medical School, Boston, 
Massachusetts, United States of America)
Institute for Molecular Systems Biology (Zurich, Switzerland)
The Ottawa Institute for Systems Biology (Ottawa, Canada)
 DOI:  10.1371/journal.pmed.0030208.t002 
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  Figure 1.   E. coli   Chemotaxis 
    E. coli  has been observed to migrate toward areas of higher aspartate concentrations through 
a series of “runs” and “tumbles” (see Box 1).
  Autophosph,  autophosphorylation. PLoS Medicine  |  www.plosmedicine.org 0713
stable functioning despite various 
perturbations [25,26]. Natural systems 
speciﬁ  cally demonstrate an uncanny 
penchant for robustness, which, 
as many have argued, is necessary 
for natural systems to survive and 
procreate [27]. Robustness is attained 
by ﬁ  ve described mechanisms: 
feedback control, structural stability, 
redundancy, modularity, and 
adaptation (see Box 2) [13,28]. 
Biological systems across all scales, 
from cells to organisms, rely on a 
combination of these mechanisms to 
maintain a semblance of stability. The 
human body is no exception.
    The stability discussed in systems 
biology is distinct from the stability 
commonly perceived in clinical 
medicine. Medical practitioners often 
picture stability as an unwavering 
entity such that values are maintained 
within a speciﬁ  c, conﬁ  ned range. But 
stability in systems biology is revealed 
dynamically, and it is the   behavior   of 
the system rather than the   state   of the 
system that remains consistent. This 
dynamic stability can assume many 
forms, including homeostatic, bistable 
(having two stable states), oscillatory, 
or chaotic [29]. Normal biological 
functions can be classiﬁ  ed into one of 
these dynamic behaviors: for instance, 
bacteriophage lysis-lysogeny as bistable, 
circadian rhythms as oscillatory, or 
heart rate variability as chaotic. This 
varied perspective of stability is more 
extensive than the commonly accepted 
notion of homeostasis and may 
ultimately inﬂ  uence how treatments are 
deliberated.
    Lessons from Systems Biology
    The fundamental disconnect that 
exists between clinical medicine and 
systems biology largely stems from 
their disparate worldviews—one 
focuses on the parts and the other on 
the systems. As a consequence, the 
factors of time, space, and context, 
which are considered vital for a system-
level understanding, are not assigned 
the same level of importance in 
medicine as they are in systems biology. 
Moreover, system-level concepts such as 
robustness, stability, and variability do 
not have meaningful equivalents in the 
medical vernacular. The incorporation 
of such concepts into medicine may 
help address certain limitations 
and greatly enhance its therapeutic 
potential. The second article in 
this series will explore how systems 
medicine may be realized in practice.   
June 2006  |  Volume 3  |  Issue 6  |  e208
 Box  2
   Feedback  control:  Serves to correct 
deviations and restores the system to its 
natural behavior.
   Structural  stability:  Explains for the 
stability that arises from the very nature 
of the network structure. For instance, 
the World Wide Web was shown to be 
resistant to random attacks to Web sites 
by virtue of its organization [30]. 
   Redundancy:  Allows for functionally 
equivalent units to substitute for one 
another in the event of a failure.
   Modularity:  Prevents ampliﬁ  cation of 
a perturbation by dividing function or 
structure into subunits or modules.
   Adaptation:  Promotes survival and 
functioning in a variety of environmental 
conditions.  
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